| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.057 | 0.3 |